Where does Novamont S.p.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Novamont S.p.A. ranks #4,166 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Novamont S.p.A. hold?

Novamont S.p.A. holds 86 US utility patents granted between 2015 and 2025, spanning 41 technology areas.

What is Novamont S.p.A.'s Innovation Score?

Novamont S.p.A. has an Innovation Score of 53.5 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Novamont S.p.A. focus on?

Novamont S.p.A.'s top technology area is C08L (Compositions OF Macromolecular Compounds) with 44 patents. Grants appear in 41 CPC subclasses total.

Is Novamont S.p.A.'s patent grant rate increasing or decreasing?

Novamont S.p.A.'s recent grant velocity is +13% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Novamont S.p.A.'s patents?

Novamont S.p.A.'s patents average 17.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Novamont S.p.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Novamont S.p.A.

USPTO PatentsView assignee record - 86 granted patents across 41 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08L (Compositions OF Macromolecular Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Novamont ranks #4,166 of 49,997 tracked US assignees by granted-patent volume, with 86 patents across 41 technology areas.

#4,166
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.5/100): 17.8
avg claims per patent: +13%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4166 · Foreign Corporation #4,166 · 86 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 86 grants
TOP-DECILE #4,166/49,997
PHOTO-FINISH Means Industries
CPC-WIDE C08L · 41 areas
INNOV-PAR 53.5/100
CLAIMS-RICH 17.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +13% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Means Industries, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Bekaert · near

54
Airspan IP Holdco · near

54
ArianeGroup SAS · near

54
Hangzhou Great Star… · near

54
Novamont S p A · this assignee

54
3D Lighting… · lowest

7

What this shows Novamont's Innovation Score is 53.5/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Novamont's grants concentrate

Novamont S.p.A. is a focused PatentsView assignee: 41 CPC subclasses with 51.2% of grants classified under C08L (Compositions OF Macromolecular Compounds). Peak complete grant year is 2020 (14 grants) versus a trough of 4 in 2015. By volume, Novamont sits between Mochida Pharmaceutical Co., Ltd. and Radian Memory Systems, Illc.

Novamont's three-year grant acceleration

From 2019–2021 to 2022–2024, Novamont S.p.A. moved from 32 to 23 grants (0.72x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Mochida Pharmaceu…

86
Means Industries

86
National Presto I…

86
Neturen

86
Protegrity

86
Plastic Omnium Ad…

86
Robe lighting s r…

86
Radian Memory Sys…

86
Novamont S p A ◀

86

What this shows Novamont holds 86 patents at rank #4,166, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Novamont

By rank, the assignees closest to #4,166 in granted patent volume.

Leaders in C08L (Compositions OF Macromolecular Compounds)

Other assignees with the most granted patents in Novamont's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Novamont, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (54 here).

ArianeGroup SAS 54 Hangzhou Great Star Industrial Co., Ltd. 54 Airspan IP Holdco LLC 54 NV Bekaert SA 54

Similar claim depth

Nearest assignees by average claims per patent (17.8 here).

Csem Centre Suisse D'electronique ET DE Microtechnique SA—RECHERCHE ET DÉVELOPPEMENT 17.8 avg University of Leeds 17.8 avg Avid Technology, Inc. 17.8 avg Verizon Digital Media Services Inc. 17.8 avg

Novamont's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Novamont S.p.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	4.7%
2016	7	8.1%
2017	5	5.8%
2018	12	14.0%
2019	11	12.8%
2020	14	16.3%
2021	7	8.1%
2022	13	15.1%
2023	6	7.0%
2024	4	4.7%
2025partial year	3	3.5%

Which technologies does Novamont S.p.A. patent most?

C08L - Compositions OF Macromolecular Compounds 44

C07C - Acyclic OR Carbocyclic Compounds 25

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 25

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 24

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 20

Y02W - Climate Change Mitigation Technologies Related TO Wastewater Treatment OR Waste Management 17

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 13

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 13

C11C - Fatty Acids From Fats, Oils OR WAXES; CANDLES; Fats, Oils OR Fatty Acids BY Chemical Modification OF Fats, Oils, OR Fatty Acids Obtained Therefrom 11

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 10

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 10

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 9

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 9

Y10T - Technical Subjects Covered BY Former US Classification 8

Top 15 of 41 technology areas

Where it ranks

Overall rank by patents

#4,166

of 49,997 tracked assignees

Innovation Score

53.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Novamont S.p.A.'s patent record in context - here's where to go next.

Novamont S.p.A.'s lead technology class is C08L (Compositions OF Macromolecular Compounds), 51.2% of its portfolio - see every assignee active in that class. Explore C08L
Ranked #4,166 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Novamont S.p.A. against Mochida Pharmaceutical Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.